Press releases | WebDisclosure

Basculer en Français

10401	Companies
217318	Keywords
146966	Articles
115051	Press releases

Home
Press releases

PRESS RELEASE

published on 07/01/2024 at 13:00, 1 year 10 months ago

Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals

Supervisory Board Radiopharmaceuticals Pentixapharm AG Marcus Quinkler Endocrinologist
PRESS RELEASE

published on 07/01/2024 at 12:48, 1 year 10 months ago

Total Voting Rights
M&G Credit Income Investment Trust plc announces total voting rights as at 30 June 2024. Share capital: 141,944,239 Ordinary Shares. Excludes 2,801,532 shares held in treasury

Share Capital Ordinary Shares M&G Credit Income Investment Trust Plc Total Voting Rights Financial Conduct Authority
PRESS RELEASE

published on 07/01/2024 at 12:30, 1 year 10 months ago

US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Zomedica Corp.'s PulseVet Shock Wave Device named Official Shock Wave Therapy Supplier of US Equestrian team veterinarians for major international team events. Partnership with USEF to enhance equine athlete care

Zomedica Corp. Veterinary Health US Equestrian PulseVet Shock Wave Device Equine Athletes
PRESS RELEASE

published on 07/01/2024 at 12:30, 1 year 10 months ago

NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections
NanoViricides, Inc. elaborates on its lead broad-spectrum antiviral drug candidate NV-387, poised to revolutionize viral disease treatment. Plans include Phase II studies for RSV and market expansion

NV-387 NanoViricides Inc. Antiviral Drug Viral Diseases Phase II Studies
PRESS RELEASE

published on 07/01/2024 at 12:10, 1 year 10 months ago

Report de l'approbation des comptes 2023 au 31 octobre 2024 au plus tard
GAUSSIN obtient un délai pour arrêter et publier ses comptes 2023 accordé par le Tribunal de commerce de Vesoul. Euronext transfère temporairement les actions sur le compartiment 'Penalty Bench'

Euronext Tribunal De Commerce Comptes 2023 GAUSSIN Penalty Bench
PRESS RELEASE

published on 07/01/2024 at 12:10, 1 year 10 months ago

Report de l'approbation des comptes 2023 au 31 octobre 2024 au plus tard
GAUSSIN annonce le report de l'approbation des comptes 2023 au 31 octobre 2024 suite a une situation exceptionnelle. Euronext transfère temporairement ses actions dans le compartiment 'Penalty Bench'

Euronext Report Comptes 2023 GAUSSIN Penalty Bench
PRESS RELEASE

published on 07/01/2024 at 12:09, 1 year 10 months ago

DM1 au BP 2024
REGULATED PRESS RELEASE

published on 07/01/2024 at 12:06, 1 year 10 months ago

GUILLEMOT CORPORATION: Weekly report share buyback From June 24th 2024 to June 28th 2024
Guillemot Corporation S.A. reports share buyback transactions on Euronext Paris from June 24th to 28th, 2024, executed by an independent provider

Euronext Paris Share Buyback Financial Report Guillemot Corporation Investment Services Provider
REGULATED PRESS RELEASE

published on 07/01/2024 at 12:06, 1 year 10 months ago

GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres Du 24 juin 2024 au 28 juin 2024
Déclaration hebdomadaire des transactions sur actions propres de Guillemot Corporation S.A. du 24/06/2024 au 28/06/2024. Transactions conformes à la réglementation

Actions Propres Rachat D'actions Euronext Paris Transactions Guillemot Corporation
PRESS RELEASE

published on 07/01/2024 at 12:02, 1 year 10 months ago

CS MEDICA Stock Now Also Traded on XETRA
CS MEDICA A/S shares now available for trading on XETRA, offering increased liquidity and trading opportunities. Private bank ensures liquidity provision as Designated Sponsor

Liquidity Trading XETRA CS MEDICA A/S Designated Sponsor

Accesswire

Published on 05/13/2026 at 19:25, 1 hour 18 minutes ago

Bolt Metals Executes Option to Acquire The High-Grade Floralia Iron Project, Prepares for Maiden Drill Program at Northwind
Published on 05/13/2026 at 15:30, 5 hours 13 minutes ago

All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 5 hours 38 minutes ago

Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 5 hours 43 minutes ago

ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 5 hours 43 minutes ago

Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program

View all ACCESSWIRE

EQS Group

Published on 05/13/2026 at 20:21, 22 minutes ago

Northern Data provides operational update
Published on 05/13/2026 at 20:18, 25 minutes ago

EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 1 hour 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 1 hour 29 minutes ago

EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond
Published on 05/13/2026 at 18:15, 2 hours 28 minutes ago

Africa Energy Forum 2026: Building Africa's Industrialised Future

Les Echos

Published on 05/13/2026 at 18:02, 2 hours 41 minutes ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 2 hours 43 minutes ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 2 hours 43 minutes ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 2 hours 43 minutes ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 2 hours 58 minutes ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.

View all LES ECHOS COMFI WIRE